La vendita allo scoperto per Horizon Tech Finance dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Horizon Tech Finance. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Horizon Tech Finance (NASDAQ:HRZN) Azioni, Report sulle vendite allo scoperto

Horizon Tech Finance

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services and sustainability industries.

Horizon Technology Finance Corporation - Common Stock

Horizon Technology Finance Corp

Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.35 by 8.57 percent. This is a 39.62 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $24.56 million which missed the analyst consensus estimate of $25.49 million by 3.64 percent. This is a 15.70 percent decrease over sales of $29.14 million the same period last year.

Earnings

Earnings Misses

News

HRZN

Horizon Tech Finance Q3 EPS $0.32 Misses $0.35 Estimate, Sales $24.56M Miss $25.49M Estimate

Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) is preparing to release its quarterly earnings on Tuesday, 2024-10-29. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Horizon Tech Finance to report an earnings per share (EPS) of $0.35.
The market awaits Horizon Tech Finance's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 3.48% drop in the share price the next day.
Here's a look at Horizon Tech Finance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.36</td>
<td>0.39</td>
<td>0.44</td>
<td>0.41</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.36</td>
<td>0.38</td>
<td>0.45</td>
<td>0.53</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>3.0%</td>
<td>-7.000000000000001%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730138569_0.png" alt="eps graph" />
<h3>Tracking Horizon Tech Finance's Stock Performance</h3>
Shares of Horizon Tech Finance were trading at $10.07 as of October 25. Over the last 52-week period, shares are down 8.8%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/HRZN/earnings">To track all earnings releases for Horizon Tech Finance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Horizon Tech Finance's Earnings

Horizon Technology Finance Provides Q3 2024 Update; Originates $93.1M In New Loans, Ends Quarter With $189.9M Committed Backlog, And Receives $37.5M In Principal Prepayments; Closes $172.9M In New Loan Commitments And Expects $35M In Additional Opportunities Pending Final Approval

B. Riley Securities analyst Bryce Rowe reiterates Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) with a Sell and lowers the price target from $10 to $9.

Price Target

Reiteration

Analyst Ratings

B. Riley Securities Reiterates Sell on Horizon Tech Finance, Lowers Price Target to $9

Keefe, Bruyette &amp; Woods analyst Paul Johnson maintains Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) with a Underperform and lowers the price target from $9.5 to $9.

Keefe, Bruyette & Woods Maintains Underperform on Horizon Tech Finance, Lowers Price Target to $9

Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) reported quarterly earnings of $0.36 per share which met the analyst consensus estimate. This is a 33.33 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $25.678 million which beat the analyst consensus estimate of $25.317 million by 1.43 percent. This is a 8.67 percent decrease over sales of $28.117 million the same period last year.

Earnings Beats

Horizon Tech Finance Q2 2024 GAAP EPS $0.36, Inline, Sales $25.678M Beat $25.317M Estimate

- HRZN Originates $11.5 Million of New Loans in Q2 - - HRZN Ends Quarter with Committed Backlog of $138 Million -
Horizon Technology Finance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) ("Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the second quarter ended June 30, 2024 and an update on the lending platform ("Horizon Platform") of Horizon Technology Finance Management LLC ("HTFM"), its investment adviser.
"We maintained a thoughtful approach to new investments in the quarter and originated a modest number of investments for HRZN, while we observed clear signs of improvement in the venture environment," said Gerald A. Michaud, President of HRZN and HTFM. "We believe such signs, buoyed by our $138 million committed backlog of debt investments, which provides us with a solid foundation for new debt investments, may afford HRZN the opportunity to meaningfully grow its investment portfolio in the second half of the year. Additionally, we were pleased to receive approximately $34 million in loan payoffs in the second quarter, generating accelerated income and prepayment fees. As we look ahead, we believe HRZN remains well positioned to deliver additional value to its shareholders."
Second Quarter 2024 Portfolio Update
Originations
During the second quarter of 2024, HRZN funded a total of $11.5 million of loans and $0.5 million of equity, as follows:
<ul>
<li>$5.0 million to a new portfolio company, a fulfillment and supply chain technology services company focused on optimizing logistics across a variety of industries.</li>
<li>$5.0 million to an existing portfolio company, Supply Network Visibility Holdings LLC (d/b/a Everstream Analytics), a provider of supply chain risk management software.</li>
<li>$1.0 million of debt and $0.5 million of equity to an existing affiliated portfolio company, a builder of conservation memorial forests that offer sustainable alternatives to cemeteries.</li>
<li>$0.5 million to an existing portfolio company, Nexii Building Solutions Inc., a green construction technology company focused on creating environmentally-friendly, durable, cost-efficient and disaster-resilient buildings.</li>
</ul>

Horizon Technology Finance Provides Q2 2024 Portfolio Update; Originates $11.5M Of New Loans In Q2;  Ends Quarter With Committed Backlog Of $138M

Horizon Technology Finance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that Horizon Funding II, LLC, Horizon's wholly-owned subsidiary ("HFII"), has closed a $100 million senior secured credit facility led by a large U.S. based insurance company pursuant to which HFII may issue up to $100 million of secured notes. The capacity under the credit facility may be increased to $200 million with the mutual agreement of Horizon and the lenders.
Horizon intends to use the credit facility to leverage its existing investments, as well as deploy additional capital for new investments. The new credit facility complements the Company's existing credit facilities.

Financing

Horizon Technology Finance Enhances Capital Resources And Increases Capacity Via New $100M Credit Facility

Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) reported quarterly earnings of $0.38 per share which missed the analyst consensus estimate of $0.40 by 5 percent. This is a 17.39 percent decrease over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $26.129 million which missed the analyst consensus estimate of $26.596 million by 1.76 percent. This is a 6.81 percent decrease over sales of $28.037 million the same period last year.

Horizon Tech Finance Q1 2024 GAAP EPS $0.38 Misses $0.40 Estimate, Sales $26.129M Miss $26.596M Estimate

- HRZN Originates $33.5 Million of New Loans in Q1 -
- HRZN Ends Quarter with Committed Backlog of $168 Million -
Horizon Technology Finance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) ("Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the first quarter ended March 31, 2024 and an update on the lending platform ("Horizon Platform") of Horizon Technology Finance Management LLC ("HTFM"), its investment adviser.
"HRZN funded $34 million in new loans in the first quarter, as we continued to monitor the changing venture environment and maintained our cautious approach," said Gerald A. Michaud, President of HRZN and HTFM. "We are now seeing some green shoots in our markets which we find encouraging. While we watch these developments, we continue to maintain a significant committed backlog of debt investments, which totaled $168 million as of March 31. Our backlog should provide a solid foundation for new debt investments to existing and new portfolio companies in the quarters ahead."
"During the quarter, we also received $20 million in loan payoffs and partial paydowns, generating accelerated income and prepayment fees, which added to our regular investment income from interest on our outstanding debt investments," added Mr. Michaud. "Looking forward, we believe HRZN remains well positioned to prudently grow its portfolio of debt investments, while delivering additional value to HRZN's shareholders."
First Quarter 2024 Portfolio Update
Originations
During the first quarter of 2024, HRZN funded a total of $33.5 million of loans, as follows:
<ul>
<li>$15.0 million to an existing portfolio company, Sonex Health, Inc., a developer of technology, education and training programs for ultrasound guided procedures.</li>
<li>$14.0 million to an existing portfolio company, Ceribell, Inc., a developer of an FDA-cleared rapid response electroencephalography (EEG) medical device, which measures the amount of electrical activity in different regions of the brain in order to diagnose seizures.</li>
<li>$2.5 million to an existing portfolio company, a developer of a cloud-native software platform for the property and casualty insurance segment.</li>
<li>$1.8 million to an existing portfolio company, Nexii Building Solutions Inc., a green construction technology company focused on creating environmentally-friendly, durable, cost-efficient and disaster-resilient buildings.</li>
<li>$0.2 million to an existing portfolio company, Robin Healthcare, Inc., a developer of an AI device that silently observes healthcare visits, extracts data, then builds and uploads clinical notes to a patient's electronic health record.</li>
</ul>
Liquidity Events and Partial Paydowns
HRZN experienced liquidity events from three portfolio companies in the first quarter of 2024, including principal prepayments and partial paydowns of $19.8 million, compared to $48.3 million of principal prepayments and partial paydowns during the fourth quarter of 2023:
<ul>
<li>In February, with the proceeds of a new loan from the Horizon Platform, Ceribell, Inc. ("Ceribell") paid its outstanding principal balance of $11.2 million on its venture loan, plus interest and end-of-term payment. HRZN continues to hold warrants in Ceribell.</li>
<li>In March, HRZN received a principal paydown of $1.1 million on its venture loans to NextCar Holding Company, Inc. ("NextCar"). HRZN continues to hold warrants in NextCar.</li>
<li>In March, Engage3, LLC paid its outstanding principal balance of $7.5 million on its venture loan, plus interest, end-of-term payment and prepayment fee.</li>
</ul>
Principal Payments Received
During the first quarter of 2024, HRZN received regularly scheduled principal payments on investments totaling $10.5 million, compared to regularly scheduled principal payments totaling $13.2 million during the fourth quarter of 2023.
Commitments
During the quarter ended March 31, 2024, HRZN closed new loan commitments totaling $37.5 million to three companies, compared to new loan commitments of $89.4 million to four companies in the fourth quarter of 2023.
Pipeline and Term Sheets
As of March 31, 2024, HRZN's unfunded loan approvals and commitments ("Committed Backlog") were $168.2 million to 14 companies. This compares to a Committed Backlog of $218.3 million to 15 companies at HRZN as of December 31, 2023. HRZN's portfolio companies have discretion whether to draw down such commitments and the right of a portfolio company to draw down its commitment is often subject to achievement of specific milestones and other conditions to borrowing. Accordingly, there is no assurance that any or all of these transactions will be funded by HRZN. Across the Horizon Platform, the quarter ended with an additional $4.7 million of unfunded loan approvals and commitments.
During the quarter, HTFM received a signed term sheet that is in the approval process, which may result in the Horizon Platform providing up to an aggregate of $10.0 million of new debt investments. These opportunities are subject to underwriting conditions including, but not limited to, the completion of due diligence, negotiation of definitive documentation and investment committee approval, as well as compliance with HTFM's allocation policy. Accordingly, there is no assurance that any or all of these transactions will be completed or funded by HRZN.
Warrant and Equity Portfolio
As of March 31, 2024, HRZN held a portfolio of warrant and equity positions in 99 portfolio companies, including 87 private companies, which provides the potential for future additional returns to HRZN's shareholders.

Horizon Technology Finance Provides First Quarter 2024 Portfolio Update; Originates $33.5M Of New Loans In Q1; Ends Quarter With Committed Backlog Of $168M

UBS analyst Vilas Abraham maintains Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) with a Neutral and lowers the price target from $11.5 to $10.5.

UBS Maintains Neutral on Horizon Tech Finance, Lowers Price Target to $10.5

Friday marks the last chance for investors to receive the next dividend payout from Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 11 cents per share. On Monday, Horizon Tech Finance will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 11 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own HRZN as of the end of Friday's session are eligible to receive the 11 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on April 16, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Dividends

Friday Is Your Last Chance To Buy Horizon Tech Finance Before The Dividend Payout

Keefe, Bruyette &amp; Woods analyst Paul Johnson maintains Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) with a Underperform and lowers the price target from $10 to $9.5.

Keefe, Bruyette & Woods Maintains Underperform on Horizon Tech Finance, Lowers Price Target to $9.5

Oppenheimer analyst Mitchel Penn maintains Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) with a Perform and lowers the price target from $11 to $10.

Oppenheimer Maintains Perform on Horizon Tech Finance, Lowers Price Target to $10

Ladenburg Thalmann analyst Christopher Nolan downgrades Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) from Buy to Neutral.

Downgrades

Ladenburg Thalmann Downgrades Horizon Tech Finance to Neutral

Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.33 by 36.36 percent. This is a 12.5 percent increase over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $28.18 million which beat the analyst consensus estimate of $27.85 million by 1.21 percent. This is a 21.77 percent increase over sales of $23.14 million the same period last year.

Horizon Tech Finance Q4 2023 GAAP EPS $0.45 Beats $0.33 Estimate, Sales $28.18M Beat $27.85M Estimate

ACAD

ACHC

AESI

AHCO

AIRS

ALEC

ALHC

AMBA

AMBC

APLS

ARKO

ARQT

ARRY

ATEC

AXON

BCSF

BECN

BGFV

BMBL

BWXT

BYND

CAVA

CBRL

CIVI

CLDT

CLNE

CLVT

CMLS

COMP

CPNG

CRDO

CYTK

EBAY

EHTH

ESPR

FARO

FLYW

FOUR

FSLR

FULC

GDOT

GLPI

GMRE

GSX Techedu Inc. American Depositary Shares

GOTU

GPOR

HSIC

HURN

ICCC

ICFI

ICUI

IMAX

IMXI

INGN

INSE

IPAR

JAMF

KIND

KURA

KVYO

LAZR

LGND

LGVN

Earnings Scheduled For February 27, 2024

Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-02-27. Here's what investors need to know before the announcement.
Analysts estimate that Horizon Tech Finance will report an earnings per share (EPS) of $0.44. 
Horizon Tech Finance bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.12, which was followed by a 4.78% increase in the share price the next day.
Here's a look at Horizon Tech Finance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.43</td>
<td>0.40</td>
<td>0.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.53</td>
<td>0.54</td>
<td>0.46</td>
<td>0.40</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>1.0%</td>
<td>4.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1708970524_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Horizon Tech Finance were trading at $12.99 as of February 23. Over the last 52-week period, shares are up 5.33%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/HRZN/earnings">To track all earnings releases for Horizon Tech Finance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Horizon Tech Finance

Tuesday marks the last chance for investors to receive the next dividend payout from Horizon Tech Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 11 cents per share. On Wednesday, Horizon Tech Finance will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 11 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday. Shareholders who own HRZN as of the end of Tuesday's session are eligible to receive the 11 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on February 14, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Horizon Tech Finance <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Horizon Tech Finance: Dividend Insights

- HRZN Originates $63.4 Million of New Loans in Q4 - - HRZN Ends 2023 with Committed Backlog of $218 Million - &nbsp;&nbsp;
FARMINGTON, Conn., Jan. 10, 2024 /PRNewswire/ --&nbsp;Horizon Technology Finance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRZN#NASDAQ">HRZN</a>) ("Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the fourth quarter ended December 31, 2023 and an update on the lending platform ("Horizon Platform") of Horizon Technology Finance Management LLC ("HTFM"), its investment adviser.
"We closed out the year with another solid quarter of quality originations at the Horizon Platform, including $63 million of loans funded by HRZN," said Gerald A. Michaud, President of HRZN and HTFM. "We are pleased to announce that, during the quarter, HRZN completed its first co-investment with funds managed by Monroe Capital, a direct benefit to Horizon from HTFM's access to Monroe's substantial investment platform. In addition to the new originations in the quarter, HRZN's committed backlog of debt investments increased to $218 million. HRZN also received $48 million in loan payoffs and partial paydowns during the quarter, generating additional accelerated income and further validating our predictive pricing strategy. Entering 2024, we remain well positioned to further grow HRZN's venture debt portfolio and deliver additional value to HRZN's shareholders."
Fourth Quarter 2023 Portfolio Update
Originations&nbsp;
During the fourth quarter of 2023, HRZN funded a total of $63.4 million of loans, as follows:
<ul>
<li>$32.5 million to a new portfolio company, VERO Biotech, Inc., a developer of innovative nitric oxide delivery technology for the acute care setting. The loan is HRZN's first co-investment with Monroe Capital. This funding will support the continued commercial expansion of the GENOSYL&#xAE; Delivery System (GENOSYL&#xAE; DS), as well as other R&amp;D initiatives.</li>
<li>$10.0 million to a new portfolio company, Parse Biosciences, Inc., a provider of accessible and scalable single cell sequencing solutions.</li>
<li>$7.5 million to a new portfolio company, MicroTransponder, Inc., the developer of the Vivistim Paired VNS System, the only FDA-approved neurostimulation device designed to improve stroke recovery by restoring 2-3 times more motor function in a stroke survivor's hand and arm compared to traditional rehabilitation therapy.</li>
<li>$6.5 million to an existing portfolio company, TemperPack Technologies, Inc., a manufacturer of sustainable insulated packaging for perishable last mile deliveries.</li>
<li>$5.0 million to an existing portfolio company, a developer of innovative medical devices and therapies to address the evolving needs of interventional specialists.</li>
<li>$1.9 million to an existing portfolio company, Nexii Building Solutions Inc., a green construction technology company focused on creating environmentally-friendly, durable, cost-efficient and disaster-resilient buildings.</li>
</ul>
Liquidity Events and Partial Paydowns
HRZN experienced liquidity events from four portfolio companies in the fourth quarter of 2023, including principal prepayments and partial paydowns of $48.3 million, compared to $37.9 million of principal prepayments and partial paydowns during the third quarter of 2023:&nbsp;
<ul>
<li>In October, HRZN received a principal paydown of $11.0 million on its venture loans to Evelo Biosciences, Inc.</li>
<li>In December, Primary Kids, Inc. ("Primary Kids") paid its outstanding principal balance of $5.1 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in Primary Kids.</li>
<li>In December, Infobionic, Inc. ("Infobionic") paid its outstanding principal balance of $2.2 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in Infobionic.</li>
<li>In December, Magnolia Medical Technologies, Inc. ("Magnolia") paid its outstanding principal balance of $30.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee. HRZN continues to hold warrants in Magnolia.</li>
</ul>
Principal Payments Received&nbsp;
During the fourth quarter of 2023, HRZN received regularly scheduled principal payments on investments totaling $11.8 million, compared to regularly scheduled principal payments totaling $9.1 million during the third quarter of 2023.
Commitments
During the quarter ended December 31, 2023, HRZN closed new loan commitments totaling $89.4 million to four companies, compared to new loan commitments of $157.7 million to seven companies in the third quarter of 2023.
Pipeline and Term Sheets&nbsp;
As of December 31, 2023, HRZN's unfunded loan approvals and commitments ("Committed Backlog") were $218.3 million to 15 companies. This compares to a Committed Backlog of $201.8 million to 19 companies at HRZN as of September 30, 2023. HRZN's portfolio companies have discretion whether to draw down such commitments and the right of a portfolio company to draw down its commitment is often subject to achievement of specific milestones and other conditions to borrowing.&nbsp; Accordingly, there is no assurance that any or all of these transactions will be funded by HRZN. Across the Horizon Platform, the quarter ended with an additional $10.5 million of unfunded loan approvals and commitments.
During the quarter, HTFM received signed a term sheet that is in the approval process, which may result in the Horizon Platform providing up to an aggregate of $20.0 million of new debt investments. These opportunities are subject to underwriting conditions including, but not limited to, the completion of due diligence, negotiation of definitive documentation and investment committee approval, as well as compliance with HTFM's allocation policy. Accordingly, there is no assurance that any or all of these transactions will be completed or funded by HRZN.
Warrant and Equity Portfolio
As of December 31, 2023, HRZN held a portfolio of warrant and equity positions in 103 portfolio companies, including 89 private companies, which provides the potential for future additional returns to HRZN's shareholders.

Horizon Technology Finance Provides Q4 2023 Portfolio Update; Originates $63.4M Of New Loans In Q4; Ends 2023 With Committed Backlog Of $218M

8.19% From Horizon Baby Bonds Comes With Low Duration And Decent Credit Score

Here are the major earnings after the close today

Horizon Technology Finance GAAP EPS of $0.32 misses by $0.03

"We had a solid third quarter, as we originated a number of new, high-quality loans that returned our portfolio to quarter-over-quarter growth, whi...

Horizon Technology reports Q3 NII 32c per share vs. 53c last year

Horizon Technology Finance (HRZN) Q3 2024 Earnings Call Transcript

Oppenheimer analyst Mitchel Penn maintained a Hold rating on Horizon Technology (HRZN – Research Report) today and set a price target of $9.00. The...

Horizon Technology (HRZN) Gets a Hold from Oppenheimer

Undercovered Dozen: Dassault Systemes, Intrum, Itochu, Two Harbors +

Horizon Technology: The Level Of Speculation Has Increased After Q3

BDC Weekly Review: Capital Southwest Investors Didn't Like The Earnings

This week, several dividend stocks are trading close to their 52-week lows. Here is a list of ten such stocks that are also reaching their ex-divid...

Ex-Dividend Date Nearing for These 10 Stocks – Week of November 11, 2024

ALSN

APAM

ARCH

ATGE

ATOM

BMRN

BRSP

CAKE

CEIX

CHCT

CSWC

CTRE

DASTF

DASTY

ENVX

EXEL

EXLS

FDUS

GLCNF

GLNCY

GOOG

HTFB

HTFC

ILPT

INJJF

ITJTY

ITOCF

ITOCY

JBGS

LBTYA

LBTYK

LFUS

LFVN

LSTR

LYSCF

MDLZ

MEDP

MFIN

NNOMF

OXSQ

PILBF

PRTS

QRVO

RDDT

REYN

RMBS

RPRX

SAGE

SNAP

STAG

TNEYF

TRTX

VRNS

WERN

WYGPF

WYGPY

Press Releases

Horizon Technology Finance Management Announces Executive Promotions

Horizon Technology Finance Provides $35 Million Venture Loan Facility to Vesta Healthcare

Vesta Healthcare Raises $65 Million in Financing to Propel Growth

Horizon Technology Finance Provides $35 Million Venture Loan Facility to GT Medical Technologies

GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance

Horizon Technology Finance Provides Third Quarter 2024 Portfolio Update

Horizon Technology Finance to Announce Third Quarter 2024 Financial Results

Horizon Technology Finance Announces Third Quarter 2024 Financial Results

Horizon Technology Finance Announces Monthly Distributions for January, February and March 2025 Totaling $0.33 per Share

Horizon Technology Finance Provides $10 Million Venture Loan Facility to Ursa Space Systems

AlTi Global

ArrowMark Financial Corp. - Closed End Fund

ArrowMark Financial

Comments

Horizon Tech Finance

Vendite allo scoperto

Horizon Tech Finance (NASDAQ:HRZN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO